Trial to Assess Safety and Efficacy of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN)
Clinical trial NCT04145440 · COMPLETED
Trial details
- NCT number
- NCT04145440
- Sponsor
- HI-Bio, A Biogen Company
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-15
- Primary completion
- 2022-01-19
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.